DLG4 and Alzheimer disease: Furthermore, the injection of CTR NSC-derived EVs in a mouse model of Alzheimer's disease (AD) led to an increase in GAP43, synaptophysin, and PSD-95 synaptic markers in the cortex when compared to vehicle-injected animals 33.